Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Adam C. Ehrlich, Shyam Patel, Andrew Meillier, Robin D. Rothstein & Frank K. Friedenberg. (2017) Chemoprevention of colorectal cancer in inflammatory bowel disease. Expert Review of Anticancer Therapy 17:3, pages 247-255.
Read now
Read now
Anders Rönnblom, Tommy Holmström, Urban Karlbom, Hans Tanghöj, Mari Thörn & Daniel Sjöberg. (2017) Clinical course of Crohn’s disease during the first 5 years. Results from a population-based cohort in Sweden (ICURE) diagnosed 2005–2009. Scandinavian Journal of Gastroenterology 52:1, pages 81-86.
Read now
Read now
Makoto Nakano, Shiro Oka, Shinji Tanaka, Sayoko Kunihara, Atushi Igawa, Taiki Aoyama, Hiroki Imagawa, Seiji Onogawa, Yoshitaka Ueno, Keiji Hanada & Kazuaki Chayama. (2016) Clinical usefulness of transabdominal ultrasonography prior to patency capsule for suspected small-bowel strictures. Scandinavian Journal of Gastroenterology 51:3, pages 281-287.
Read now
Read now
Articles from other publishers (20)
Eduardo J. Villablanca, Katja Selin & Charlotte R. H. Hedin. (2022) Mechanisms of mucosal healing: treating inflammatory bowel disease without immunosuppression?. Nature Reviews Gastroenterology & Hepatology 19:8, pages 493-507.
Crossref
Crossref
Marina Fortea, Mercé Albert-Bayo, Mar Abril-Gil, John-Peter Ganda Mall, Xavier Serra-Ruiz, Alejandro Henao-Paez, Elba Expósito, Ana María González-Castro, Danila Guagnozzi, Beatriz Lobo, Carmen Alonso-Cotoner & Javier Santos. (2021) Present and Future Therapeutic Approaches to Barrier Dysfunction. Frontiers in Nutrition 8.
Crossref
Crossref
Gerardo Cazzato, Anna Colagrande, Valeria Andriola, Teresa Lettini, Sebastiano Cicco, Pragnell Mary Victoria Candance, Leonardo Resta, Leonardo Vincenti & Giuseppe Ingravallo. (2021) Histological Hallmarks of Mucosal Healing in Inflammatory Bowel Diseases in the Era of Monoclonal Antibodies Therapy: New Insights and Perspectives. Diagnostics 11:9, pages 1570.
Crossref
Crossref
Debashis Sahoo, Lee Swanson, Ibrahim M. Sayed, Gajanan D. Katkar, Stella-Rita Ibeawuchi, Yash Mittal, Rama F. Pranadinata, Courtney Tindle, Mackenzie Fuller, Dominik L. Stec, John T. Chang, William J. Sandborn, Soumita Das & Pradipta Ghosh. (2021) Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease. Nature Communications 12:1.
Crossref
Crossref
Robert Benamouzig, Stéphanie Barré, Jean-Christophe Saurin, Henri Leleu, Alexandre Vimont, Sabrine Taleb & Frédéric De Bels. (2021) Cost-effectiveness analysis of alternative colorectal cancer screening strategies in high-risk individuals. Therapeutic Advances in Gastroenterology 14, pages 175628482110023.
Crossref
Crossref
Christopher G Fenton, Hagar Taman, Jon Florholmen, Sveinung W Sørbye & Ruth H Paulssen. (2021) Transcriptional Signatures That Define Ulcerative Colitis in Remission. Inflammatory Bowel Diseases 27:1, pages 94-105.
Crossref
Crossref
S. Barré, H. Leleu, A. Vimont, A. Kaufmanis, I. Gendre, S. Taleb & F. De Bels. (2020) Estimation de l’impact du programme actuel de dépistage organisé du cancer colorectal. Revue d'Épidémiologie et de Santé Publique 68:3, pages 171-177.
Crossref
Crossref
Stéphanie Barré, Henri Leleu, R. Benamouzig, Jean-Christophe Saurin, Alexandre Vimont, Sabrine Taleb & Frédéric De Bels. (2020) Cost-effectiveness analysis of alternative colon cancer screening strategies in the context of the French national screening program. Therapeutic Advances in Gastroenterology 13, pages 175628482095336.
Crossref
Crossref
Mónica Romera-Hernández, Patricia Aparicio-Domingo, Natalie Papazian, Julien J. Karrich, Ferry Cornelissen, Remco M. Hoogenboezem, Janneke N. Samsom & Tom Cupedo. (2020) Yap1-Driven Intestinal Repair Is Controlled by Group 3 Innate Lymphoid Cells. Cell Reports 30:1, pages 37-45.e3.
Crossref
Crossref
Joseph Diab, Terkel Hansen, Rasmus Goll, Hans Stenlund, Einar Jensen, Thomas Moritz, Jon Florholmen & Guro Forsdahl. (2019) Mucosal Metabolomic Profiling and Pathway Analysis Reveal the Metabolic Signature of Ulcerative Colitis. Metabolites 9:12, pages 291.
Crossref
Crossref
Arno R. Bourgonje, Julius Z. H. von Martels, Ruben Y. Gabriëls, Tjasso Blokzijl, Manon Buist-Homan, Janette Heegsma, Bernadien H. Jansen, Hendrik M. van Dullemen, Eleonora A. M. Festen, Rinze W. F. ter Steege, Marijn C. Visschedijk, Rinse K. Weersma, Paul de Vos, Klaas Nico Faber & Gerard Dijkstra. (2019) A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease. Frontiers in Medicine 6.
Crossref
Crossref
Joseph Diab, Terkel Hansen, Rasmus Goll, Hans Stenlund, Maria Ahnlund, Einar Jensen, Thomas Moritz, Jon Florholmen & Guro Forsdahl. (2019) Lipidomics in Ulcerative Colitis Reveal Alteration in Mucosal Lipid Composition Associated With the Disease State. Inflammatory Bowel Diseases 25:11, pages 1780-1787.
Crossref
Crossref
Katarzyna Neubauer, Malgorzata Matusiewicz, Iwona Bednarz-Misa, Sabina Gorska, Andrzej Gamian & Malgorzata Krzystek-Korpacka. (2018) Diagnostic Potential of Systemic Eosinophil-Associated Cytokines and Growth Factors in IBD. Gastroenterology Research and Practice 2018, pages 1-10.
Crossref
Crossref
Aleksandar Acovic, Bojana Simovic Markovic, Marina Gazdic, Aleksandar Arsenijevic, Nemanja Jovicic, Nevena Gajovic, Marina Jovanovic, Natasa Zdravkovic, Tatjana Kanjevac, C. Randall Harrell, Crissy Fellabaum, Zana Dolicanin, Valentin Djonov, Nebojsa Arsenijevic, Miodrag L. Lukic & Vladislav Volarevic. (2018) Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis. Therapeutic Advances in Gastroenterology 11, pages 175628481879355.
Crossref
Crossref
Hadar Reichman, Italy Moshkovits, Michal Itan, Metsada Pasmanik-Chor, Thomas Vogl, Johannes Roth & Ariel Munitz. (2017) Transcriptome profiling of mouse colonic eosinophils reveals a key role for eosinophils in the induction of s100a8 and s100a9 in mucosal healing. Scientific Reports 7:1.
Crossref
Crossref
Konstantinos Papamichael, Filip Baert, Sophie Tops, Gert Van Assche, Paul Rutgeerts, Severine Vermeire, Ann Gils & Marc Ferrante. (2017) Post-Induction Adalimumab Concentration is Associated with Short-Term Mucosal Healing in Patients with Ulcerative Colitis. Journal of Crohn's and Colitis 11:1, pages 53-59.
Crossref
Crossref
Konstantinos Papamichael, Thomas Van Stappen, Niels Vande Casteele, Ann Gils, Thomas Billiet, Sophie Tops, Karolien Claes, Gert Van Assche, Paul Rutgeerts, Severine Vermeire & Marc Ferrante. (2016) Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology 14:4, pages 543-549.
Crossref
Crossref
Trine Olsen, Renathe Rismo, Mona Dixon Gundersen, Eyvind J. Paulssen, Knut Johnsen, Jan-Magnus Kvamme, Rasmus Goll & Jon Florholmen. (2016) Normalization of mucosal tumor necrosis factor-α: A new criterion for discontinuing infliximab therapy in ulcerative colitis. Cytokine 79, pages 90-95.
Crossref
Crossref
Yosuke Kurashima & Hiroshi Kiyono. 2016. Chronic Inflammation. Chronic Inflammation
567
590
.
Makoto NaganumaNaoki HosoeTakanori KanaiHaruhiko Ogata. (2015) Recent trends in diagnostic techniques for inflammatory bowel disease. The Korean Journal of Internal Medicine 30:3, pages 271.
Crossref
Crossref